104 related articles for article (PubMed ID: 17317369)
21. Association of the metabolic syndrome with early coronary disease in families with frequent myocardial infarction.
Reinhard W; Holmer SR; Fischer M; Gloeckner C; Hubauer U; Baessler A; Mayer B; Schunkert H; Riegger GA; Hengstenberg C
Am J Cardiol; 2006 Apr; 97(7):964-7. PubMed ID: 16563895
[TBL] [Abstract][Full Text] [Related]
22. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events.
Mak KH; Ma S; Heng D; Tan CE; Tai ES; Topol EJ; Chew SK
Am J Cardiol; 2007 Jul; 100(2):227-33. PubMed ID: 17631075
[TBL] [Abstract][Full Text] [Related]
23. Admission glycemia: a predictor of death after acute coronary syndrome in non-diabetic patients?
Rocha S; Nabais S; Magalhães S; Salgado A; Azevedo P; Marques J; Torres M; Pereira MA; Correia A
Rev Port Cardiol; 2007 Dec; 26(12):1367-77. PubMed ID: 18338666
[TBL] [Abstract][Full Text] [Related]
24. Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation.
Rogers J; Stratta RJ; Lo A; Alloway RR
Transplant Proc; 2005 Oct; 37(8):3549-51. PubMed ID: 16298657
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.
Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2006; 7(1):7-11. PubMed ID: 16513517
[TBL] [Abstract][Full Text] [Related]
27. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes.
Segev A; Strauss BH; Tan M; Buller CE; Mendelsohn AA; Langer A; Goodman SG;
Int J Cardiol; 2008 Sep; 129(2):233-7. PubMed ID: 17976842
[TBL] [Abstract][Full Text] [Related]
29. [Influence of admission glucose level on long-term prognosis in patients with acute coronary syndrome].
Macín SM; Perna ER; Coronel ML; Kriskovich JO; Bayol PA; Franciosi VA; Riera-Stival JL; González-Arjol B; Badaracco JR
Rev Esp Cardiol; 2006 Dec; 59(12):1268-75. PubMed ID: 17194422
[TBL] [Abstract][Full Text] [Related]
30. Gender based differences in patients with acute coronary syndrome: findings from Chinese Registry of Acute Coronary Events (CRACE).
Song XT; Chen YD; Pan WQ; Lü SZ;
Chin Med J (Engl); 2007 Jun; 120(12):1063-7. PubMed ID: 17637223
[TBL] [Abstract][Full Text] [Related]
31. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
Pambianco G; Costacou T; Orchard TJ
Diabetes Care; 2007 May; 30(5):1248-54. PubMed ID: 17303788
[TBL] [Abstract][Full Text] [Related]
32. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention.
Kasai T; Miyauchi K; Kurata T; Okazaki S; Kajimoto K; Kubota N; Daida H
Hypertens Res; 2008 Feb; 31(2):235-41. PubMed ID: 18360042
[TBL] [Abstract][Full Text] [Related]
33. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
34. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
[TBL] [Abstract][Full Text] [Related]
36. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
Gazzaruso C; Solerte SB; De Amici E; Mancini M; Pujia A; Fratino P; Giustina A; Garzaniti A
Am J Cardiol; 2006 Jan; 97(2):236-9. PubMed ID: 16442369
[TBL] [Abstract][Full Text] [Related]
37. Social support level in relation to metabolic syndrome--results of the SOPKARD study.
Pakalska-Korcala A; Zdrojewski T; Piwoński J; Gil K; Chwojnicki K; Ignaszewska-Wyrzykowska A; Mielczarek M; Radziwiłłowicz P; Landowski J; Wyrzykowski B
Kardiol Pol; 2008 May; 66(5):500-5, discussion 506. PubMed ID: 18537057
[TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
39. The effect of the public or private status of health care facility in acute coronary syndrome: data from Thai ACS Registry.
Hutayanon P; Sarakarn P; Buakhamsri A; Boonsom W; Yamwong S
J Med Assoc Thai; 2007 Oct; 90 Suppl 1():98-108. PubMed ID: 18431892
[TBL] [Abstract][Full Text] [Related]
40. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
